Acibadem Expands into Third Largest City in Turkiye as Part of Growth Strategy; Acquires Izmir Kent Hospital
Thursday, February 02, 2023
Acibadem Healthcare Group (“Acibadem”), a subsidiary of IHH Healthcare, announced today that it has entered definitive agreements to acquire 100% of Kent Health Group (“Kent”), a leading private healthcare service provider in Izmir, Turkiye.
Founded in 2004, Kent operates the largest private hospital in Izmir – the 340-bed Izmir Kent Hospital with an attached cancer center – as well as two medical centers in the city.
Mr. Mehmet Ali Aydınlar, Founder and Chairman of Acibadem, said: “We are proud to bring the Acibadem brand to Izmir, which is the third largest city in Turkiye. This transaction aligns with our growth strategy in the country and achieves our long-awaited goal to serve the people of Izmir. We are pleased to be providing our services to the community by adding Kent Health Group, a prominent player in Izmir’s private healthcare arena, to our portfolio.”
Mr. Matthew Strassberg, Chairman of Kent and Partner at MidEuropa, which currently manages Kent, said: “Over the past decade, MidEuropa has actively supported Kent’s management team as we invested to more than double Kent’s capacity, including the greenfield construction of a state-of-the-art oncology center and the opening of a new satellite facility. The acquisition by Acibadem validates the strategic value generated by Kent though these investments and ensures the continuity of focus on medical and service excellence for the benefit of patients and other stakeholders.”
Izmir Kent Hospital will be Acibadem’s 19th hospital in Turkiye and 25th globally. The number of medical centers in Acibadem’s network will increase to 16 with this acquisition.
The transaction is expected to close during the first quarter of 2023 following the completion of necessary regulatory approvals.
For further information, please contact:
Evren Gence
Deputy CEO,
Strategy and Business Development
evren.gence@acibadem.com
Ceren Tarhanlı
Senior Legal Counsel
ceren.tarhanli@acibadem.com
ABOUT ACIBADEM HEALTHCARE GROUP
Acibadem is a part of IHH Healthcare, one of the world’s largest healthcare providers. With its full spectrum of integrated services, dedicated people, reach and scale, and commitment to quality and safety, IHH aspires to be the world’s most trusted healthcare services network, united by a single purpose: to touch lives and transform care. More information on Acibadem can be found at http://www.acibadem.com/en/.
ABOUT IHH HEALTHCARE
A world-leading integrated healthcare provider, IHH believes that making a difference starts with our aspiration to Care. For Good.
Our team of 65,000 people commit to deliver greater good to our patients, our people, the public and our planet, as we live our purpose each day to touch lives and transform care.
Through our portfolio of trusted brands – Acibadem, Mount Elizabeth, Prince Court, Gleneagles, Fortis, Pantai, Parkway and IMU – we offer our patients comprehensive and personalised care ranging from primary to quaternary, and even ancillary services such as laboratory, diagnostics, imaging and rehabilitation.
With our scale and reach in 10 countries, we continue to raise the bar in healthcare in our key markets of Malaysia, Singapore, Turkiye, India, Greater China (including Hong Kong), and beyond.
In partnership with our stakeholders, we will co-create a sustainable future for all as we work towards our vision to be the world’s most trusted healthcare services network.
More information can be found at www.ihhhealthcare.com.